Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Counselling and entry into HIV care
ISRCTN ISRCTN94133652
ClinicalTrials.gov identifier
Public title Counselling and entry into HIV care
Scientific title Assessing the effect of extended counselling on uptake and adherence to pre- antiretroviral care: A longitudinal, randomised controlled trial
Acronym pre-ARV
Serial number at source MUSPH 06012009
Study hypothesis Extended counselling is associated with increased uptake and adherence to pre-antiretroviral therapy (ART)
Lay summary Not provided at time of registration
Ethics approval 1. Makerere University School of Public Health Higher Degrees Research and Ethics Committee approved on the 6th of January 2009
2. Uganda National Council for Science and Technology approved
Study design Longitudinal double blind multicentre randomised controlled trial
Countries of recruitment Uganda
Disease/condition/study domain Pre-ARV care adherence
Participants - inclusion criteria Adult patients (>18 yrs) who test HIV positive at the ART centres at the start of the study (November 2009)
Participants - exclusion criteria 1. Patients undergoing Prevention of Mother-To-Child Transmission (PMTCT) therapy
2. Patients who are not of sound mental status
3. Those who are expected to leave the district during the period of follow-up
Anticipated start date 02/12/2009
Anticipated end date 02/06/2010
Status of trial Completed
Patient information material Please contact Dr Muhamadi Lubega [dlmuhamadi@yahoo.co.uk] to request a patient information sheet
Target number of participants 400
Interventions Newly screened HIV positive persons will be followed and monitored for uptake and adherence to the pre-ART care for a period of 5 months depending on the frequency of enrolment of eligible subjects. The HIV positive persons from three centres will be classified into two arms.
1. Control arm: HIV positive persons will receive the current format and text of counselling
2. Intervention arm: HIV positive persons will receive a specially packaged continuum of extended counselling
Primary outcome measure(s) Proportion of HIV positive persons with extended counselling who adhere to pre-ART care
Secondary outcome measure(s) Proportion of HIV positive persons not lost to follow up during subsequent HIV care
Sources of funding Swedish International Development Authority - Department for Research Cooperation (SIDA/SAREC) (Sweden)
Trial website
Publications 1. 2010 results in http://www.ncbi.nlm.nih.gov/pubmed/20022131
2. 2011 results in http://www.ncbi.nlm.nih.gov/pubmed/21794162
Contact name Prof  Fred  Wabwire-Mangeni
  Address Makerere University
School of Public Health
PO BOX 7072
  City/town Kampala
  Zip/Postcode 256
  Country Uganda
  Email fwabwire@musph.ac.ug
Sponsor Swedish International Development Authority - Department for Research Cooperation (SIDA/SAREC) (Sweden)
  Address Karolinska institutet
Stockholm
c/o Makerere University
PO BOX 7072
  City/town Kampala
  Zip/Postcode 256
  Country Uganda
  Email stefan.peterson@ki.se
  Sponsor website: http://www.sida.se
Date applied 01/06/2010
Last edited 22/11/2011
Date ISRCTN assigned 13/07/2010
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central